|
Real-time Estimate
Cboe BZX
12:01:00 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 83.22 USD | -3.02% |
|
-7.34% | +4.52% |
| 06:02am | UnitedHealthcare to expand program paying pharmacists for medical services | RE |
| 11-16 | CVS Health's Stock Rebound Reflects Market Acknowledgement of Business Separation Merits, RBC Says | MT |
| Market Cap | 110B 99.67B 92.07B 83.06B 157B 10,258B 163B 1,109B 439B 5,535B 412B 403B 17,489B | P/E 2026 * |
12.2x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 163B 148B 137B 123B 233B 15,226B 242B 1,647B 651B 8,216B 611B 599B 25,959B | EV / Sales 2026 * |
0.39x | EV / Sales 2027 * | 0.37x |
| Free-Float |
71.21% | Yield 2026 * |
3.09% | Yield 2027 * | 3.18% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
| CVS | Real-time | ||
| CVS * | End-of-day quote | ||
| CVS | Real-time | ||
| 0HRS | Delayed | ||
| CVS | Real-time | ||
| CVSUS | End-of-day quote | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | End-of-day quote | ||
| CVS | End-of-day quote | ||
| 1CVS | End-of-day quote | ||
| CVSCL | End-of-day quote | ||
| 0HRS | Real-time | ||
| Real-time | |||
| CVS | Delayed | ||
| CVS | Delayed |
Last Transcript: CVS Health Corporation
| 1 day | -3.39% | ||
| 1 week | -7.53% | ||
| Current month | -8.28% | ||
| 1 month | -10.68% | ||
| 3 months | -12.78% | ||
| 6 months | -13.76% | ||
| Current year | +4.31% |
| 1 week | 82.34 | 90.71 | |
| 1 month | 77.33 | 95.26 | |
| Current year | 69.51 | 110.68 | |
| 1 year | 69.51 | 110.68 | |
| 3 years | 43.56 | 110.68 | |
| 5 years | 43.56 | 111.25 | |
| 10 years | 43.56 | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/6/26 | Buy | Executive/Senior Manager | 23,855 | 0.0019% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.32% | -7.53% | +6.21% | +21.27% | 110B | ||
| -3.01% | -3.80% | +1.81% | +95.96% | 105B | ||
| -1.55% | -11.94% | +31.82% | +414.04% | 41.68B | ||
| -0.32% | +0.73% | +10.26% | +97.14% | 33.35B | ||
| -0.15% | -1.38% | +41.30% | +73.90% | 29.9B | ||
| +0.57% | -0.43% | +38.99% | +91.00% | 28.2B | ||
| -2.32% | -5.53% | +43.40% | +326.11% | 22.45B | ||
| -1.37% | -2.56% | -18.66% | -20.58% | 19.79B | ||
| -0.50% | +2.33% | -3.41% | +33.11% | 17.18B | ||
| -0.44% | -3.72% | +121.62% | - | 14.55B | ||
| Average | -1.23% | -1.25% | +27.33% | +125.77% | 42B | |
| Weighted average by Cap. | -1.98% | -2.09% | +17.05% | +110.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 422B 383B 354B 319B 603B 39,432B 626B 4,265B 1,687B 21,278B 1,583B 1,550B 67,227B | 431B 392B 362B 326B 616B 40,308B 640B 4,359B 1,724B 21,751B 1,619B 1,585B 68,722B |
| Net income | 8.99B 8.16B 7.53B 6.8B 12.83B 839B 13.32B 90.79B 35.91B 453B 33.71B 33B 1,431B | 9.44B 8.57B 7.92B 7.14B 13.49B 882B 14B 95.41B 37.74B 476B 35.43B 34.68B 1,504B |
| Net Debt | 53.18B 48.27B 44.59B 40.23B 75.95B 4,968B 78.86B 537B 213B 2,681B 200B 195B 8,470B | 48.78B 44.28B 40.9B 36.9B 69.66B 4,557B 72.33B 493B 195B 2,459B 183B 179B 7,770B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | US$83.03 | -3.24% | 5,368,766 |
| 26-11-17 | US$85.81 | -3.14% | 13,620,793 |
| 26-11-16 | US$88.59 | -0.85% | 11,780,922 |
| 26-11-13 | US$89.35 | -0.49% | 8,019,995 |
| 26-11-12 | US$89.79 | +0.30% | 11,792,301 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions

















